Motor neuropathy due to docetaxel and paclitaxel Journal Article


Authors: Freilich, R. J.; Balmaceda, C.; Seidman, A. D.; Rubin, M.; DeAngelis, L. M.
Article Title: Motor neuropathy due to docetaxel and paclitaxel
Abstract: Paclitaxel and docetaxel are novel chemotherapeutic agents that promote the polymerization and inhibit the depolymerization of microtubules. Sensory neuropathy is common with these agents, particularly paclitaxel. We evaluated 64 patients treated with these drugs; 54 were followed prospectively. Eleven (17%, including six of the 54 prospectively followed patients) developed muscle weakness that was predominantly proximal. The weakness was idiosyncratic occurring at any stage of treatment, had a variable course, and was reversible upon cessation of drug. All patients developed symptoms or signs of taxane-induced sensory neuropathy. Weakness was likely neuropathic in origin; electrodiagnostic studies suggested a distal axonopathy in some patients and proximal denervation (anterior horn cell or nerve root) in others.
Keywords: adult; cancer chemotherapy; aged; middle aged; major clinical study; paclitaxel; ovary cancer; sensory neuropathy; breast cancer; lung non small cell cancer; antineoplastic agents, phytogenic; antineoplastic activity; docetaxel; muscle weakness; electromyography; taxoids; microtubule; depolymerization; motor neuropathy; motor neuron disease; humans; human; priority journal; article
Journal Title: Neurology
Volume: 47
Issue: 1
ISSN: 0028-3878
Publisher: Lippincott Williams & Wilkins  
Date Published: 1996-07-01
Start Page: 115
End Page: 118
Language: English
PUBMED: 8710063
PROVIDER: scopus
DOI: 10.1212/WNL.47.1.115
DOI/URL:
Notes: Article -- Export Date: 22 November 2017 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Andrew D Seidman
    318 Seidman